nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—HRH2—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.13	0.13	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0353	0.0353	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0346	0.0346	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0305	0.0305	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0297	0.0297	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0291	0.0291	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0259	0.0259	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0257	0.0257	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0209	0.0209	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0201	0.0201	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0195	0.0195	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0189	0.0189	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0185	0.0185	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0183	0.0183	CbGpPWpGaD
Famotidine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0179	0.0179	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0176	0.0176	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0171	0.0171	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0165	0.0165	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0164	0.0164	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0159	0.0159	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0156	0.0156	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0154	0.0154	CbGpPWpGaD
Famotidine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.0152	0.0152	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0143	0.0143	CbGpPWpGaD
Famotidine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0134	0.0134	CbGpPWpGaD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0126	0.0126	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.012	0.012	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0119	0.0119	CbGpPWpGaD
Famotidine—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.0106	0.0106	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.01	0.01	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00907	0.00907	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00838	0.00838	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00799	0.00799	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00777	0.00777	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00682	0.00682	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00681	0.00681	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00675	0.00675	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00667	0.00667	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00662	0.00662	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00636	0.00636	CbGpPWpGaD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00595	0.00595	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00583	0.00583	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00574	0.00574	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00572	0.00572	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0054	0.0054	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00514	0.00514	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00487	0.00487	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00462	0.00462	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00444	0.00444	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00435	0.00435	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00414	0.00414	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00404	0.00404	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00396	0.00396	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00395	0.00395	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00376	0.00376	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00376	0.00376	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00374	0.00374	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00364	0.00364	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00358	0.00358	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00353	0.00353	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00346	0.00346	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0034	0.0034	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00329	0.00329	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00325	0.00325	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00322	0.00322	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00312	0.00312	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00307	0.00307	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00303	0.00303	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00302	0.00302	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00291	0.00291	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00282	0.00282	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.0028	0.0028	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00275	0.00275	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0027	0.0027	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00264	0.00264	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00262	0.00262	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0026	0.0026	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00251	0.00251	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00249	0.00249	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00246	0.00246	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00245	0.00245	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00237	0.00237	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00233	0.00233	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00233	0.00233	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00232	0.00232	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00231	0.00231	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00231	0.00231	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00228	0.00228	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00223	0.00223	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00215	0.00215	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00214	0.00214	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00201	0.00201	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00199	0.00199	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00198	0.00198	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00197	0.00197	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00196	0.00196	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00188	0.00188	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00178	0.00178	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00171	0.00171	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00157	0.00157	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00155	0.00155	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00151	0.00151	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0015	0.0015	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.0015	0.0015	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00149	0.00149	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00139	0.00139	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00137	0.00137	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00135	0.00135	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00135	0.00135	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00134	0.00134	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00132	0.00132	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00132	0.00132	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.0013	0.0013	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00129	0.00129	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00125	0.00125	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00124	0.00124	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00123	0.00123	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00122	0.00122	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00121	0.00121	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0012	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00118	0.00118	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0011	0.0011	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000955	0.000955	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000915	0.000915	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00091	0.00091	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00085	0.00085	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.0008	0.0008	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000772	0.000772	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000743	0.000743	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00072	0.00072	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000708	0.000708	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000699	0.000699	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000651	0.000651	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000628	0.000628	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000628	0.000628	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000618	0.000618	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000574	0.000574	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000509	0.000509	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000502	0.000502	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000478	0.000478	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000456	0.000456	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00038	0.00038	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000378	0.000378	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000352	0.000352	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000352	0.000352	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000346	0.000346	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000321	0.000321	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000281	0.000281	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000268	0.000268	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000242	0.000242	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000213	0.000213	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000211	0.000211	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000205	0.000205	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000163	0.000163	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	9.13e-05	9.13e-05	CbGpPWpGaD
